PD 173074 is a selective FGFR1 and FGFR3 inhibitor. PD 173074 is a compound induced a dose-dependent reduce in cell viability and an increase in apoptosis, accompanied by a decrease in extracellular signal-related kinase phosphorylation.
Molecular Spectra
No Data Available
Click here to submit data
References
• Buchler, et al.: 9, 119 (1997)
• Keats, J., et al.: Blood, 101, 1520 (1997)
• Mohammadi, M., et al.: Science, 276, 955 (1997)
• Yagasaki, F., et al.: Cancer Res., 61, 8371 (1997)